Close Window

Digital Look Email A Friend

Midatech Pharma signs global licensing agreement with Novartis

Published by Michele Maatouk on 7th June 2017

(ShareCast News) - AIM-listed Midatech Pharma has signed a global licensing agreement with Novartis for the oncology compound panobinostat.

URL: http://www.digitallook.com/dl/news/story/26033270/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.